CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-17 | Growth Equity Opportunities 17, LLC 10% owner | Purchase | +333,333 | $3.00 | $1000K | 24,471,264 |
| 2023-06-26 | Pratt Raymond Dennis Chief Medical Officer | Purchase | +6,500 | $2.93 | $19K | 160,000 |
| 2023-05-26 | RAMSAY DAVID A Director | Purchase | +37,124 | $2.63 | $98K | 2,201,142 |
| 2023-05-25 | RAMSAY DAVID A Director | Purchase | +12,876 | $2.57 | $33K | 2,164,018 |
| 2023-05-24 | RAMSAY DAVID A Director | Purchase | +50,000 | $2.56 | $128K | 2,151,142 |
| 2023-02-24 | Lutz Robert Matthew Chief Operating Officer | Grant or award | +140,000 | 140,000 | ||
| 2023-02-24 | Lutz Robert Matthew Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2022-12-30 | RAMSAY DAVID A Director | Purchase | +29,000 | $1.55 | $45K | 2,101,142 |
| 2022-12-29 | RAMSAY DAVID A Director | Purchase | +7,000 | $1.54 | $11K | 2,072,142 |
| 2022-12-28 | RAMSAY DAVID A Director | Purchase | +3,293 | $1.50 | $5K | 2,065,142 |
| 2022-12-23 | RAMSAY DAVID A Director | Purchase | +15,707 | $1.44 | $23K | 2,061,849 |
| 2022-12-22 | Pratt Raymond Dennis Chief Medical Officer | Purchase | +3,500 | $1.54 | $5K | 153,500 |
| 2022-12-22 | RAMSAY DAVID A Director | Purchase | +41,414 | $1.48 | $61K | 2,046,142 |
| 2022-12-20 | RAMSAY DAVID A Director | Purchase | +3,586 | $1.48 | $5K | 2,004,728 |
| 2022-12-20 | RAMSAY DAVID A Director | Purchase | +13,830 | $1.50 | $21K | 2,001,142 |
| 2022-12-19 | RAMSAY DAVID A Director | Purchase | +40,719 | $1.49 | $61K | 1,987,312 |
| 2022-12-16 | RAMSAY DAVID A Director | Purchase | +341 | $1.50 | $512 | 1,946,593 |
| 2022-12-13 | McCracken Joseph S Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-12-13 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-12-13 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 8 of 11 · 202 trades